Cancer Care Costs in the United States Are Projected to Exceed $245 Billion by 2030
PHILADELPHIA – The national cancer-attributable costs in the United States are projected to increase by over 30 percent from...
PHILADELPHIA – The national cancer-attributable costs in the United States are projected to increase by over 30 percent from...
PHILADELPHIA – An analysis of 59 prostate cancer clinical trials based in North America and Europe found that the...
PHILADELPHIA – Among patients with both colorectal cancer and diabetes in Korea, those who had a high adherence to...
PHILADELPHIA – Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better...
PHILADELPHIA – An analysis of nearly 16,000 young patients with cancer in Utah revealed that exposure to fine particulate...
PHILADELPHIA – Between 2001 and 2016 in the United States, Asian/Pacific Islander men experienced the greatest increase in the...
PHILADELPHIA – Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab...
PHILADELPHIA – People who received information from the Screen to Save program, a culturally tailored initiative from the National...
PHILADELPHIA – A risk prediction model that combined genetic and clinical factors with circulating biomarkers identified people at significantly...
PHILADELPHIA – Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis, according to results...